Alcohol: role in the development of hypertension and end-stage renal disease

被引：43
|
作者：
Parekh, RS
Klag, MJ
机构：
[1] Johns Hopkins Med Inst, Dept Pediat, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA
[4] Johns Hopkins Med Inst, Dept Hlth Policy & Management, Baltimore, MD 21205 USA
来源：
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 2001年 / 10卷 / 03期
关键词：
D O I：
10.1097/00041552-200105000-00014
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Alcohol is a common risk factor in the general population for a variety of health outcomes. In the present review, we discuss the recent literature on alcohol, hypertension, and renal disease. The regular consumption of more than two drinks per day is associated with both hypertension and renal disease. The mechanisms by which consumption of alcohol leads to hypertension and perhaps renal disease are unknown. Curr Opin Nephrol Hypertens 10:385-390 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码：385 / 390
页数：6
相关论文
共 50 条
  • [31] PULMONARY HYPERTENSION IN HOSPITALIZED END-STAGE RENAL DISEASE PATIENTS
    Taweesedt, P.
    Chukiat, C.
    Edwards, P.
    Disthabanchong, S.
    NEPHROLOGY, 2016, 21 : 38 - 39
  • [32] The role of inflammation in the anaemia of end-stage renal disease
    Stenvinkel, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 36 - 40
  • [33] Association of Adolescent Hypertension With Future End-stage Renal Disease
    Leiba, Adi
    Fishman, Boris
    Twig, Gilad
    Gilad, David
    Derazne, Estela
    Shamiss, Ari
    Shohat, Tamar
    Ron, Ofir
    Grossman, Ehud
    JAMA INTERNAL MEDICINE, 2019, 179 (04) : 517 - 523
  • [34] Cumulative hypertension burden and risk of end-stage renal disease
    Kim, Chang Seong
    Kim, Bongseong
    Choi, Hong Sang
    Bae, Eun Hui
    Ma, Seong Kwon
    Han, Kyung-Do
    Kim, Soo Wan
    HYPERTENSION RESEARCH, 2021, 44 (12) : 1652 - 1661
  • [35] Anemia, hypertension, and myocardial dysfunction in end-stage renal disease
    Venkatesan, J
    Henrich, WL
    SEMINARS IN NEPHROLOGY, 1997, 17 (04) : 257 - 269
  • [36] Future role of calcimimetics in end-stage renal disease
    Goodman, WG
    Turner, SA
    ADVANCES IN RENAL REPLACEMENT THERAPY, 2002, 9 (03): : 200 - 208
  • [37] The Role of Aldosterone Blockade in End-Stage Renal Disease
    Pitt, Bertram
    Saran, Rajiv
    CARDIOLOGY, 2009, 114 (01) : 30 - 31
  • [38] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514
  • [39] END-STAGE RENAL DISEASE IN INDONESIA: TREATMENT DEVELOPMENT
    Prodjosudjadi, Wiguno
    Suhardjono, A.
    ETHNICITY & DISEASE, 2009, 19 (01) : 33 - 36
  • [40] Factors influencing the development of end-stage renal disease
    Iseki K.
    Clinical and Experimental Nephrology, 2005, 9 (1) : 5 - 14
12345